Maria Rita Fumagalli
Overview
Explore the profile of Maria Rita Fumagalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erreni M, Fumagalli M, DAnna R, Sollai M, Bozzarelli S, Nappo G, et al.
Front Immunol
. 2024 Nov;
15:1472433.
PMID: 39575252
Introduction: Pancreatic ductal adenocarcinoma (PDAC) represents the complexity of interaction between cancer and cells of the tumor microenvironment (TME). Immune cells affect tumor cell behavior, thus driving cancer progression. Cancer-associated...
2.
Erreni M, Fumagalli M, Zanini D, Candiello E, Tiberi G, Parente R, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338669
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. PDAC is characterized by a complex tumor microenvironment (TME), that plays a pivotal role in disease progression and resistance...
3.
Rigamonti A, Viatore M, Polidori R, Rahal D, Erreni M, Fumagalli M, et al.
Cancer Res
. 2024 Feb;
84(7):1165-1177.
PMID: 38315789
Significance: Leveraging artificial intelligence-powered H&E analysis integrated with hi-plex imaging mass cytometry provides insights into the tumor ecosystem and can translate tumor features into classifiers to predict prognosis, genotype, and...
4.
Parente R, Fumagalli M, Di Claudio A, Cardenas Rincon C, Erreni M, Zanini D, et al.
Pathogens
. 2023 Sep;
12(9).
PMID: 37764949
The recognition of microbe and extracellular matrix (ECM) is a recurring theme in the humoral innate immune system. Fluid-phase molecules of innate immunity share regulatory roles in ECM. On the...
5.
Cioce M, Fumagalli M, Donzelli S, Goeman F, Canu V, Rutigliano D, et al.
J Exp Clin Cancer Res
. 2023 Jul;
42(1):170.
PMID: 37460938
Background: Approximately 20-50% of patients presenting with localized colorectal cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major prognostic determinant. Here, we have...
6.
Fumagalli M, Saro S, Tajana M, Zapperi S, La Porta C
iScience
. 2023 Jan;
26(1):105868.
PMID: 36624837
The metabolic activity of all the micro-organism composing the human microbiome interacts with the host metabolism contributing to human health and disease in a way that is not fully understood....
7.
Chiara Lionetti M, Fumagalli M, La Porta C
Cells Tissues Organs
. 2022 Dec;
213(2):120-132.
PMID: 36509081
Tumor plasticity is an emerging property of tumor cells which allows them to change their phenotype in dependence on the environment. The epithelial-mesenchymal transition plays a crucial role in helping...
8.
Chiara Lionetti M, Fumagalli M, La Porta C
Cancer Drug Resist
. 2022 May;
3(2):140-148.
PMID: 35582613
Melanoma is a highly aggressive tumor and almost always fatal when metastatic. Herein, we discuss recent findings on the mechanisms of resistance of human cutaneous melanoma. To achieve a precision...
9.
Ferrera L, Barbieri R, Picco C, Zuccolini P, Remigante A, Bertelli S, et al.
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445066
Tumor microenvironments are often characterized by an increase in oxidative stress levels. We studied the response to oxidative stimulation in human primary (IGR39) or metastatic (IGR37) cell lines obtained from...
10.
Fumagalli M, Zapperi S, La Porta C
J R Soc Interface
. 2021 Jul;
18(180):20210211.
PMID: 34314652
The ability of bats to coexist with viruses without being harmed is an interesting issue that is still under investigation. Here we use a mathematical model to show that the...